Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2008
09/25/2008WO2008008854A3 Cxcr4 antagonists including diazine and triazine structures for the treatment of medical disorders
09/25/2008WO2007120655A3 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators
09/25/2008US20080234494 Indolylmaleimide Derivatives
09/25/2008US20080234487 Substituted sulfoxide compounds, methods for preparing the same and use thereof
09/25/2008US20080234486 Novel Processes for the Production of Amorphous Rabeprazole Sodium
09/25/2008US20080234483 Fasudil-Containing Preparation and Method of Improving Stability Thereof
09/25/2008US20080234330 Carboxamide compounds and their use as calpain inhibitors
09/25/2008US20080234329 Carboxamide compounds and their use as calpain inhibitors
09/25/2008US20080234327 2-(benzo[d]thiazol-2-yl)-4,5-dihydro-2H-benzo[e]indazol-1-ol; hereditary hemochromatosis, anemias
09/25/2008US20080234326 Calcium (S)-bis{[5-(difluoromethoxy)]-2-[(3,4-dimethoxy-2-pyridinyl)methyl-sulphinyl]-1H-benzimidazolide}; gastrointestinal disorder
09/25/2008US20080234325 Novel Methods Using Pyridine Derivatives
09/25/2008US20080234323 solution salt formation with hydrochloric acid; easy to purify and formulate, easily reproducible and formulate; storage stable; obesity, smoking cessation, overweight, Alzheimer's disease, Parkinson's disease
09/25/2008US20080234320 Curcumin analogs with anti-tumor and anti-angiogenic properties
09/25/2008US20080234319 6-chloro-N-{[(1S,3S)-1-hydroxy-3-methylcyclohexyl]methyl}-2-[(3S)-3-hydroxypyrrolidin-1-yl]quinoline-5-carboxamide; rheumatoid arthritis
09/25/2008US20080234292 Such as S)-(1-(1-Aminobicyclo[2.2.2]oct-4-yl)aminoacetyl)-2-cyanopyrrolidine; inhibitors of the enzyme dipeptidyl peptidase; antidiabetic agents
09/25/2008US20080234287 Lung cancer, gastric cancer, liver cancer, leucocythemia, endometrioma, oophoroma, mammary cancer, colon cancer, prostatic cancer, or pituitary gland cancer; N (N',N'-dimethylaminoethyl)benzo[b]thieno[2,1-c]naphthalimide
09/25/2008US20080234286 Spray dried, stable, free-flowing solid; purity; inhibitor of tyrosine kinases and is indicated for the treatment of chronic myeloid leukemia
09/25/2008US20080234278 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
09/25/2008US20080234276 Heterocyclic Triazines as Hypoxic Selective Protein Kinase Inhibitors
09/25/2008US20080234273 Such as 3-{[4-(azetidin-1-ylcarbonyl)-2-chlorophenyl]oxy}-5-({(1S)-2-[(difluoromethyl)oxy]-1-methylethyl}oxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinases (Glk)
09/25/2008US20080234269 N-Oxo-Heterocycle and N-Oxo-Alkyl Quinoline-4-Carboxamides as Nk-3 Receptor Ligands
09/25/2008US20080234266 Squaric Acid Derivatives II
09/25/2008US20080234263 Antiproliferative agent in the prevention or treatment of tumors which are sensitive to inhibition of EGF and erbB receptor tyrosine kinases;1-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}methyl)-L-prolinamide
09/25/2008US20080234259 CB2 agonists; pain, neurodegenative disorders, eating disorders, weight loss or control, obesity, dyslipidemia, drug abuse, vision defect, neurodegenerative diseases; 5-(2,4-difluorophenyl)-4,5-diazatricyclo[5.2.1.0.sup.2,6.]deca-2-(6),3-dien-3-yl-phenylmethanone; antiinflammatory agent, antidepressant
09/25/2008US20080234254 anticarcinogenic agents for treating leukaemia, non-small cell lung cancers, colonic cancers, breast cancers, ovarian cancers, renal cancers and melanoma; in vivo hydrolysable ester or amide; N-(2-amino-phenyl)-4-[1-(3,4-dihydroisoquinolin-2(1H)-ylmethyl)vinyl]benzamide; solid phase synthesis
09/25/2008US20080234253 Alzheimer's disease, stroke, traumatic brain injury, and depression, neurodegenerative diseases; antidepressants; a phenyl thiourea or urea derivatives; promote cell proliferation of stem or progenitor cells
09/25/2008US20080234247 Heterocyclic analgesic compounds and methods of use thereof
09/25/2008US20080230743 Polyamine Derivative and Polyol Derivative
09/25/2008DE102007013812A1 New 1-azacycloalkylimidazole derivatives useful for treating cancer, malaria, cardiovascular diseases or Alzheimer's disease
09/25/2008CA2681516A1 Compounds useful as inhibitors of janus kinases
09/25/2008CA2681248A1 Chemical compounds
09/25/2008CA2681124A1 New substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
09/25/2008CA2681015A1 Inhibitors of focal adhesion kinase
09/25/2008CA2680778A1 Fused amino pyridine as hsp90 inhibitors
09/25/2008CA2680761A1 Quinoline derivatives for the treatment of inflammatory diseases
09/25/2008CA2680583A1 Pyridazinone derivatives useful as glucan synthase inhibitors
09/25/2008CA2679260A1 Novel benzamide derivatives and process for the preparation thereof
09/24/2008EP1971601A2 N4-phenyl-quinazoline-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
09/24/2008EP1971594A2 Substituted pyrazalones
09/24/2008EP1971582A1 Macrocyclic factor viia inhibitors useful as anticoagulants
09/24/2008EP1971580A1 Piperazine compounds with a herbicidal action
09/24/2008EP1971576A2 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
09/24/2008EP1723116B1 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
09/24/2008EP1572299B1 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
09/24/2008EP1513520B1 Substituted pyrrolines as kinase inhibitors
09/24/2008EP1465877B1 Positive-working photoimageable bottom antireflective coating
09/24/2008EP1322650B1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
09/24/2008CN101273035A Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4
09/24/2008CN101273034A Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4
09/24/2008CN101273033A 4- (iH-indazol-s-yl-amino)-quinazoline compounds as ERBB receptor tyrosine kinase inhibitors for the treatment of cancer
09/24/2008CN101273030A Macrocyclic inhibitors of hepatitis C virus
09/24/2008CN101273029A Bicyclic bisamide derivatives and use thereof as insecticides
09/24/2008CN101273028A Macrocyclic inhibitors of hepatitis C virus
09/24/2008CN101273027A Macrocyclic inhibitors of hepatitis C virus
09/24/2008CN101273026A Indane derivatives as MCH receptor antagonists
09/24/2008CN101273021A Selected CGRP antagonists, methods for the production thereof and their use as medicaments
09/24/2008CN101273019A Novel benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use especially as C-Met inhibitors
09/24/2008CN101273016A Antibacterial quinoline derivatives
09/24/2008CN101270087A Isoquinoline derivatives and methods of use thereof
09/24/2008CN101270081A Linear dicationic terphenyls and their aza analogues as antiparasitic agents
09/23/2008US7428705 Web map tool
09/23/2008US7427683 Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer
09/23/2008US7427682 Indole derivatives as selective androgen receptor modulators (SARMS)
09/23/2008US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease
09/23/2008US7427634 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them
09/23/2008US7427632 Factor Xa inhibitors
09/23/2008US7427631 especially as inhibitors of MMP12
09/23/2008US7427628 N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine; antiinflammatory, antiarthritic agents
09/23/2008US7427626 useful in Pharmaceutical medicines or pharmacological tools; cytostatic agents; antiproliferative/antineoplastic agents; 2-Anilino-4-[1-isopropyl-2-(hydroxyiminomethyl)imidazol-5-yl]pyrimidine; rheumatoid arthritis; breast cancer
09/23/2008US7427618 e.g. 2-[3-(4-ethynylphenyl)ureido]-N-[4-(3-oxomorpholin-4-yl)phenyl]valeramide; anticoagulant, antitumor factor; thromboses, myocardial infarction, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis after angioplasty, claudicatio intermittens, or migraine
09/23/2008US7427615 3-substituted-4-pyrimidone derivatives
09/23/2008US7427608 Protection against and treatment of hearing loss
09/23/2008CA2480800C Inhibitors of akt activity
09/23/2008CA2432872C Pyrazole compounds useful as protein kinase inhibitors
09/23/2008CA2395541C New substituted piperidines, pharmaceutical compositions containing these compounds and processes for preparing them
09/23/2008CA2337825C Disubstituted bicyclic heterocycles, the preparation thereof and their use as pharmaceutical compositions
09/23/2008CA2293373C Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase
09/23/2008CA2198238C Piperidine derivatives as neurokinin antagonists
09/23/2008CA2173703C Synergistic stabilizer mixture
09/18/2008WO2008112913A1 Inhibitors of the hedgehog pathway
09/18/2008WO2008112440A1 Piperazine and piperidine mglur5 potentiators
09/18/2008WO2008112408A1 Spiro substituted compounds as angiogenesis inhibitors
09/18/2008WO2008112407A1 Spiro substituted compounds as angiogenesis inhibitors
09/18/2008WO2008112022A1 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
09/18/2008WO2008111665A1 Polymer complex having pore and method of chemically modifying inner pore surface of polymer complex
09/18/2008WO2008111664A1 Method for synthesis of polymer complex crystal
09/18/2008WO2008111604A1 Novel pyrimidine compound having benzyl(heterocyclicmethyl)amine structure and pharmaceutical product containing the same
09/18/2008WO2008111300A1 Novel diamide derivative
09/18/2008WO2008111299A1 Novel diamide derivative
09/18/2008WO2008111077A2 Self-assembled polyhedral multimeric chemical structures
09/18/2008WO2008110891A2 New heterocyclic compounds
09/18/2008WO2008110793A1 Piperidinones useful in the treatment of inflammation
09/18/2008WO2008110611A1 Organic compounds and their uses
09/18/2008WO2008110566A1 Compounds which potentiate ampa receptor and uses thereof in medicine
09/18/2008WO2008110355A1 Quinoline derivatives as fungicides
09/18/2008WO2008110008A1 Amide derivatives as calcium channel blockers
09/18/2008WO2008109994A1 Inhibitors of histone deacetylase
09/18/2008WO2008109991A1 Inhibitors of carnitine palmitoyltransferase and treating cancer
09/18/2008WO2008109943A1 Phenyl amino pyrimidine compounds and uses thereof
09/18/2008WO2008087278A3 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy as selective ligands of v2 vasopressin receptors
1 ... 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 ... 1080